Latest News and Press Releases

CORAL GABLES, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,...

Podcast dedicated to rare disease sarcoidosis hits 100,000 downloads.

Longeveron licenses patented stem cell technology from the University of Miami.

AscellaHealth’s Patient-Focused Approach is Best-in-Class Model for Distribution of Rare Disease Therapies

FSR Early Career Fellowship Grant is designed to support early-career investigators in sarcoidosis.

PRESS RELEASE OMass Therapeutics Presents Positive Preclinical Data For its Best-in-class MC2 Program at ENDO 2025 OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH...

In total, 11 abstracts on givinostat were accepted for presentation at the Congress, including two for an oral presentation   MILAN, Italy, July 11, 2025 – Italfarmaco S.p.A. announced...

AscellaHealth Launches Q2 2025 Specialty & Rare Pipeline Digest™ to Support Stakeholders Navigating Specialty Drug Growth

Rhythm announced pricing of its upsized public offering of 2,058,824 shares of common stock at a price of $85.00 per share.

PS-002, Purespring’s lead precision nephrology programme, targets the complement pathway known to be a driver of IgA nephropathyIND clearance follows the granting of European Medicine Agency (EMA)...